These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 26348420)

  • 21. Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".
    Lewis SJ; Mueller BA
    J Intensive Care Med; 2016 Mar; 31(3):164-76. PubMed ID: 25326429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applying pharmacokinetic/pharmacodynamic principles for optimizing antimicrobial therapy during continuous renal replacement therapy.
    Honore PM; Jacobs R; De Waele E; Spapen HD
    Anaesthesiol Intensive Ther; 2017; 49(5):412-418. PubMed ID: 29171000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication dosing in critically ill patients with acute kidney injury treated with renal replacement therapy.
    Scoville BA; Mueller BA
    Am J Kidney Dis; 2013 Mar; 61(3):490-500. PubMed ID: 23127618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy.
    Pistolesi V; Morabito S; Di Mario F; Regolisti G; Cantarelli C; Fiaccadori E
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients.
    Heffernan AJ; Sime FB; Taccone FS; Roberts JA
    Curr Opin Infect Dis; 2018 Dec; 31(6):555-565. PubMed ID: 30299354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A narrative review on antimicrobial dosing in adult critically ill patients on extracorporeal membrane oxygenation.
    Kim M; Mahmood M; Estes LL; Wilson JW; Martin NJ; Marcus JE; Mittal A; O'Connell CR; Shah A
    Crit Care; 2024 Oct; 28(1):326. PubMed ID: 39367501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic therapy in sepsis: No next time for a second chance!
    Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M
    J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation.
    Bakdach D; Elajez R; Bakdach AR; Awaisu A; De Pascale G; Ait Hssain A
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients.
    Van Wart SA; Andes DR; Ambrose PG; Bhavnani SM
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):409-14. PubMed ID: 19249182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens.
    Scaglione F; Paraboni L
    Int J Antimicrob Agents; 2008 Oct; 32(4):294-301. PubMed ID: 18621508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients.
    Akers KS; Niece KL; Chung KK; Cannon JW; Cota JM; Murray CK
    J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S163-70. PubMed ID: 24770557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harmonizing antibiotic regimens with renal replacement therapy.
    Jang SM; Lewis SJ; Mueller BA
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):887-895. PubMed ID: 32362161
    [No Abstract]   [Full Text] [Related]  

  • 33. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents.
    Asín-Prieto E; Rodríguez-Gascón A; Isla A
    J Infect Chemother; 2015 May; 21(5):319-29. PubMed ID: 25737147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?
    Dhont E; Van Der Heggen T; De Jaeger A; Vande Walle J; De Paepe P; De Cock PA
    Pediatr Nephrol; 2020 Jan; 35(1):25-39. PubMed ID: 30374606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of antibiotic pharmacokinetic principles in the critically ill.
    Udy AA; Roberts JA; Lipman J
    Intensive Care Med; 2013 Dec; 39(12):2070-82. PubMed ID: 24045886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and Pharmacodynamics of Antimicrobials in Critically Ill Patients.
    Owen EJ; Gibson GA; Buckman SA
    Surg Infect (Larchmt); 2018; 19(2):155-162. PubMed ID: 29272204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit.
    Williams P; Cotta MO; Roberts JA
    Semin Respir Crit Care Med; 2019 Aug; 40(4):476-487. PubMed ID: 31585474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Pharmacology Studies in Critically Ill Children.
    Thakkar N; Salerno S; Hornik CP; Gonzalez D
    Pharm Res; 2017 Jan; 34(1):7-24. PubMed ID: 27585904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.